Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre‐Specified Analysis of Two Phase III Trials

OBJECTIVE: Anti–tumor necrosis factor (anti‐TNF) agents are frequently used in combination with methotrexate (MTX) to treat rheumatoid arthritis (RA). We investigated the effect of a background MTX dose, in combination with anti‐TNF certolizumab pegol (CZP), on treatment efficacy and safety in RA pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Care Res (Hoboken)
Autori principali: Combe, Bernard, Furst, Daniel E., Keystone, Edward C., van der Heijde, Désirée, Luijtens, Kristel, Ionescu, Lucian, Goel, Niti, Emery, Paul
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Rheumatoid Arthritis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5067694/
https://ncbi.nlm.nih.gov/pubmed/26238672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22676
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi